Funding a Smoking Cessation Program for Crohn’s Disease: An Economic Evaluation
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Funding a Smoking Cessation Program for Crohn’s Disease: An Economic Evaluation
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF GASTROENTEROLOGY
Volume 110, Issue 3, Pages 368-377
Publisher
Springer Nature
Online
2014-10-28
DOI
10.1038/ajg.2014.300
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Does Smoking Reduce Infliximab’s Effectiveness against Crohn’s Disease?
- (2016) Neeraj Narula et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- Inflammatory Bowel Disease: A Canadian Burden of Illness Review
- (2016) Angela Rocchi et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- Environment and the Inflammatory Bowel Diseases
- (2016) Alexandra Frolkis et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- Defining Quality Indicators for Best-Practice Management of Inflammatory Bowel Disease in Canada
- (2016) Geoffrey C Nguyen et al. Canadian Journal of Gastroenterology and Hepatology
- Varenicline, Smoking Cessation, and Neuropsychiatric Adverse Events
- (2013) Robert D. Gibbons et al. AMERICAN JOURNAL OF PSYCHIATRY
- Effects of Varenicline on Smoking Cessation in Adults With Stably Treated Current or Past Major Depression
- (2013) Robert M. Anthenelli et al. ANNALS OF INTERNAL MEDICINE
- Risk of Surgery for Inflammatory Bowel Diseases Has Decreased Over Time: A Systematic Review and Meta-analysis of Population-Based Studies
- (2013) Alexandra D. Frolkis et al. GASTROENTEROLOGY
- Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe — An ECCO-EpiCom study
- (2013) J. Burisch et al. Journal of Crohns & Colitis
- Cost per Treated Patient for Etanercept, Adalimumab, and Infliximab Across Adult Indications: a Claims Analysis
- (2012) Machaon M. K. Bonafede et al. ADVANCES IN THERAPY
- Assessment of Variables Associated with Smoking Cessation in Crohn’s Disease
- (2012) Yvette Leung et al. DIGESTIVE DISEASES AND SCIENCES
- High smoking cessation rate in Crohn's disease patients after physician advice – The TABACROHN Study
- (2012) Tiago Nunes et al. Journal of Crohns & Colitis
- Loss of Response and Need for Adalimumab Dose Intensification in Crohn's Disease: A Systematic Review
- (2011) Vincent Billioud et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
- (2011) Natalie A. Molodecky et al. GASTROENTEROLOGY
- Direct Medical Cost of Managing IBD Patients: A Canadian Population-based Study
- (2011) Charles N. Bernstein et al. INFLAMMATORY BOWEL DISEASES
- The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose and How to Predict Response?
- (2010) Geert R D'Haens et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Systematic review: the short-term and long-term efficacy of adalimumab following discontinuation of infliximab
- (2009) C. MA et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Loss of Response and Requirement of Infliximab Dose Intensification in Crohn's Disease: A Review
- (2009) Javier P Gisbert et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Overall and cause-specific mortality in Crohnʼs disease: A meta-analysis of population-based studies
- (2009) Dana Duricova et al. INFLAMMATORY BOWEL DISEASES
- The effect of smoking after surgery for Crohn’s disease: a meta-analysis of observational studies
- (2008) George E. Reese et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started